BioDiscovery Toronto

December 16, 2005 09:39 ET

BioDiscovery Toronto Welcomes Toronto Rehabilitation Institute

Announces David Shindler appointment as Executive Director Attention: Assignment Editor, Health/Medical Editor, News Editor, Science Editor TORONTO, ONTARIO--(CCNMatthews - Dec. 16, 2005) - BioDiscovery Toronto Welcomes the Toronto Rehabilitation Institute as a new Member and Announces the Appointment of David Shindler as Executive Director

Christopher J. Paige, Chairman of the Board of BioDiscovery Toronto and Vice-President Research at the University Health Network, announced today that the BioDiscovery Toronto Board of Directors unanimously endorsed the addition of the Toronto Rehabilitation Institute (Toronto Rehab) as the ninth member of BioDiscovery Toronto. "Toronto Rehab has an outstanding record of innovation in the field of rehabilitation science, assistive devices and technology" said Dr. Paige.

In response, Geoff Fernie, Toronto Rehab's Vice President, Research said that "the Toronto Rehabilitation Institute believes BioDiscovery Toronto presents a unique opportunity for collaboration that will leverage the resources and sophisticated management skills that are required to translate today's technological advances into successfully marketed products".

BioDiscovery Toronto's members comprise two major universities and seven leading research hospitals who have come together to provide a central 'store-front' to facilitate alliances and new ventures amongst the research community, the financial community and industry. The management and staff of BioDiscovery Toronto work closely with the university and hospital business development and technology transfer offices as well as with industry and venture capital partners to promote innovation and commercialization.

"By any measure, Toronto is a large and productive centre of basic and applied research. In 2003-04, the University of Toronto, its affiliated research hospitals and Ryerson University attracted over $550 million in external funding for research. When combined with the institutions' own support for salaries and infrastructure, it has been calculated that this group of organization spends more than $1 billion a year on research", said Dr. Paige.

"Biomedical research accounts for more than half of this activity - and that does not include research in allied disciplines, such as chemistry, materials science and information technology. Toronto constitutes the fourth largest centre of biomedical research in North America. It is also one of the most influential."

The BioDiscovery Board also announced that David Shindler has been appointed Executive Director, to lead BioDiscovery Toronto. Dr. Shindler and his team are located in the recently opened MaRS facility in the heart of Toronto's Discovery District.

"On behalf of the Board of Directors, I am delighted that Dr. Shindler has agreed to lead BioDiscovery Toronto" said Dr. Paige. He shares the BioDiscovery Toronto Board's vision for maximizing the commercialization of research in Toronto by linking research, industry and capital and is looking forward to working with Toronto's outstanding research community. He believes, as I do, that we are blessed with a critical mass of world-class bio-medical research with tremendous social and economic potential".

About BioDiscovery Toronto:
The members of BioDiscovery Toronto are the University of Toronto, Ryerson University, University Health Network, Hospital for Sick Children, Mount Sinai Hospital, Sunnybrook & Women's College Health Sciences Centre, St. Michael's Hospital, Centre for Addiction and Mental Health and now the Toronto Rehabilitation Institute. The Province of Ontario provides core funding for BioDiscovery Toronto with additional support from the federal government's Intellectual Property Mobilization Program, the National Research Council's Industrial Research Assistance Program, and the City of Toronto.

About Toronto Rehab:
The Toronto Rehabilitation Institute is at the forefront of one of the most important frontiers in health care today: rehabilitation science. As a fully affiliated teaching and research hospital of the University of Toronto, Toronto Rehab is Canada's largest provider of adult rehabilitation services, complex continuing care, and long-term care. Toronto Rehab is advancing rehabilitation knowledge and practice through research, education and patient care.

About David Shindler:
Prior to his appointment to BioDiscovery Toronto, Dr Shindler served for 6 years as President and CEO of Milestone Medica Corporation - a company associated with Royal Bank Technology Ventures and dedicated to creating new commercial ventures based on technology from Canada's leading universities and research hospitals. Between 1990 and 1998, Dr Shindler served as Senior Executive and Commercial Director of the Canadian Genetic Diseases Network, which managed major pharmaceutical deals, formed companies and attracted substantial public and private investments and international recognition. Previously, Dr Shindler was employed in Industry Canada as Manager of Canada's National Biotechnology Strategy and advised on industrial R&D policy. His international experience includes a period as Counsellor - Science and Technology at the Canadian High Commission in London, England. He holds a PhD with a specialization in microbiology from the University of Ottawa"

/For further information: Toronto Rehabilitation Institute
Jennifer Ferguson, VP, Marketing & Public Affairs
416-597-3422, ext. 3660
ferguson.jennifer@torontorehab.on.ca/ IN: EDUCATION, HEALTH, TECHNOLOGY

Contact Information